Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report.
Langrand-Escure J, Vallard A, Rivoirard R, Méry B, Guy JB, Espenel S, Trone JC, Ben Mrad M, Diao P, Rancoule C, Suchaud JP, Fournel P, Guillot A, Chargari C, Escudier B, Négrier S, Magné N.
Langrand-Escure J, et al. Among authors: chargari c.
Anticancer Drugs. 2016 Jun;27(5):427-32. doi: 10.1097/CAD.0000000000000349.
Anticancer Drugs. 2016.
PMID: 27045782